Page last updated: 2024-08-21

levonorgestrel and Fallopian Tube Neoplasms

levonorgestrel has been researched along with Fallopian Tube Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alberts, DS; Bartels, PH; Basil, J; Hunn, J; Hurteau, J; Kauderer, J; Lele, S; Modesitt, SC; Rodriguez, GC; Russell, S; Thaete, LG; Watkin, WG; Yozwiak, M; Zhang, HH; Zivanovic, O	1
Dyba, T; Koskela-Niska, V; Lyytinen, H; Pukkala, E; Ylikorkala, O	1
Grénman, S; Hurskainen, R; Mäenpää, J; Paavonen, J; Pukkala, E; Soini, T	1

Trials

1 trial(s) available for levonorgestrel and Fallopian Tube Neoplasms

Article	Year
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study. Cancer prevention research (Philadelphia, Pa.), 2019, Volume: 12, Issue:6 Topics: Adult; Aged; Apoptosis; Cell Proliferation; Contraceptive Agents, Hormonal; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Ovarian Neoplasms; Prognosis	2019

Article

Year

Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.

Cancer prevention research (Philadelphia, Pa.), 2019, Volume: 12, Issue:6

Topics: Adult; Aged; Apoptosis; Cell Proliferation; Contraceptive Agents, Hormonal; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Ovarian Neoplasms; Prognosis

2019

Other Studies

2 other study(ies) available for levonorgestrel and Fallopian Tube Neoplasms

Article	Year
Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma. International journal of cancer, 2015, Oct-15, Volume: 137, Issue:8 Topics: Aged; Aged, 80 and over; Case-Control Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Fallopian Tube Neoplasms; Female; Finland; Humans; Levonorgestrel; Logistic Models; Middle Aged; Postmenopause; Risk Factors	2015
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube. Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:11 Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Fallopian Tube Neoplasms; Female; Finland; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Neoplasms; Risk Factors	2016

Article

Year

Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.

International journal of cancer, 2015, Oct-15, Volume: 137, Issue:8

Topics: Aged; Aged, 80 and over; Case-Control Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Fallopian Tube Neoplasms; Female; Finland; Humans; Levonorgestrel; Logistic Models; Middle Aged; Postmenopause; Risk Factors

2015

Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.

Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:11

Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Fallopian Tube Neoplasms; Female; Finland; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Neoplasms; Risk Factors

2016